QRG Capital Management Inc. Purchases 34,397 Shares of Oracle Corporation $ORCL

Key Points

• QRG Capital Management increased its Oracle position by 12.9% in the second quarter, purchasing 34,397 shares and bringing its holdings to 300,056 shares valued at approximately $43.97 million.
• Oracle reported quarterly earnings of $1.92 per share and revenue of $19.34 billion, beating analyst expectations; revenue rose 29.6% year over year. Analysts maintain a consensus “Moderate Buy” rating with a $252.58 price target.
• Oracle shares fell 3.2% to $144.44, while CEO Michael Sicilia sold 10,882 shares under a pre-arranged trading plan. The company also declared a quarterly dividend of $0.50 per share, representing a 1.4% annualized yield.

QRG Capital Management Inc. boosted its position in shares of Oracle Corporation (NYSE:ORCL - Free Report) by 12.9% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 300,056 shares of the enterprise software provider's stock after purchasing an additional 34,397 shares during the quarter. QRG Capital Management Inc.'s holdings in Oracle were worth $43,973,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also bought and sold shares of ORCL. Basepoint Wealth LLC bought a new stake in shares of Oracle in the fourth quarter valued at about $26,000. Basso Capital Management L.P. bought a new position in Oracle during the 4th quarter worth about $29,000. Maseco LLP bought a new position in Oracle during the 1st quarter worth about $29,000. Persistent Asset Partners Ltd purchased a new position in Oracle during the 2nd quarter valued at about $29,000. Finally, Markowski Investments purchased a new position in Oracle during the 2nd quarter valued at about $32,000. 42.44% of the stock is owned by institutional investors.

Insider Buying and Selling at Oracle

In other news, CEO Michael Sicilia sold 10,882 shares of the firm's stock in a transaction on Wednesday, September 16th. The stock was sold at an average price of $139.94, for a total value of $1,522,827.08. Following the completion of the sale, the chief executive officer owned 149,084 shares of the company's stock, valued at $20,862,814.96. This trade represents a 6.80% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 40.90% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on ORCL. Citigroup reaffirmed a "market outperform" rating on shares of Oracle in a research report on Friday, September 11th. Royal Bank Of Canada cut their price objective on shares of Oracle from $190.00 to $165.00 and set a "sector perform" rating on the stock in a report on Friday, September 11th. Scotiabank reduced their price objective on shares of Oracle from $241.00 to $215.00 and set a "sector outperform" rating for the company in a research note on Wednesday, September 9th. Guggenheim restated a "buy" rating and set a $400.00 target price on shares of Oracle in a report on Tuesday, September 8th. Finally, BTIG Research reaffirmed a "buy" rating and set a $400.00 target price on shares of Oracle in a research report on Friday, June 5th. Two analysts have rated the stock with a Strong Buy rating, thirty have assigned a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $252.58.

Oracle Stock Down 3.2%

Shares of Oracle stock traded down $4.76 on Wednesday, reaching $144.44. The stock had a trading volume of 22,584,953 shares, compared to its average volume of 29,321,357. The company has a quick ratio of 1.17, a current ratio of 1.17 and a debt-to-equity ratio of 1.89. The stock has a market capitalization of $436.75 billion, a P/E ratio of 22.64, a P/E/G ratio of 1.06 and a beta of 1.74. The company has a 50 day moving average price of $142.15 and a 200 day moving average price of $160.41. Oracle Corporation has a 1 year low of $114.50 and a 1 year high of $322.54.

Oracle (NYSE:ORCL - Get Free Report) last posted its earnings results on Thursday, September 10th. The enterprise software provider reported $1.92 EPS for the quarter, beating analysts' consensus estimates of $1.74 by $0.18. Oracle had a net margin of 26.36% and a return on equity of 48.85%. The company had revenue of $19.34 billion during the quarter, compared to analysts' expectations of $19.13 billion. During the same quarter in the prior year, the company posted $1.47 earnings per share. Oracle's revenue for the quarter was up 29.6% compared to the same quarter last year. Oracle has set its Q2 2027 guidance at 1.850-1.930 EPS and its FY 2027 guidance at 8.100-8.100 EPS. As a group, equities research analysts forecast that Oracle Corporation will post 6.67 EPS for the current year.

Oracle Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 23rd. Stockholders of record on Friday, October 9th will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 1.4%. The ex-dividend date is Friday, October 9th. Oracle's dividend payout ratio is currently 31.35%.

Oracle News Summary

Here are the key news stories impacting Oracle this week:

• Positive Sentiment: Oracle expanded its Digital Assets Data Nexus with payment-execution integrations, configurable wallet and smart-contract controls, and AI-assisted risk oversight. The enhancements could support growth in banking and digital-money workloads. Oracle Expands Digital Assets Data Nexus
• Positive Sentiment: New Oracle Health offerings—including an oncology electronic health record, AI-powered revenue-cycle management and expanded life-sciences analytics—strengthen Oracle’s position in healthcare technology and could create longer-term subscription opportunities. Oracle Oncology EHR
• Positive Sentiment: Oracle’s collaboration with the Buck Institute and its partnership with Wipro on cloud-based pharmacovigilance services broaden applications for Oracle Health and Life Sciences data platforms. Oracle and Buck Institute Collaboration
• Neutral Sentiment: Customer adoption remained visible through Co-op Live’s use of Oracle Simphony Cloud POS and NetSuite, while FlashGrid added support for Oracle AI Database 26ai. These announcements validate demand but provided no near-term financial guidance. Co-op Live Oracle Cloud Applications
• Negative Sentiment: Investors continued to focus on reports of more than 500 U.S. cloud-infrastructure layoffs, including engineers and developers. The cuts may improve efficiency, but also raise questions about execution and demand. Oracle Cloud Layoffs
• Negative Sentiment: Concerns about Project Jupiter’s data-center financing, rising borrowing costs and negative free cash flow are making the company’s AI buildout appear increasingly capital-intensive. This could limit valuation despite strong cloud demand and backlog growth. Oracle Debt and Layoff Concerns

Oracle Company Profile

Oracle Corporation is a global enterprise technology company that develops and provides database software, cloud infrastructure, business applications and related technology services. Its offerings help organizations manage data, run applications, support business operations and build technology environments across on-premises, hybrid and cloud-based settings.

The company's products include Oracle Database, MySQL, Java, Oracle Cloud Infrastructure and a broad portfolio of cloud applications for enterprise resource planning, financial management, human resources, supply chain management, customer experience and industry-specific operations.

Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Corporation (NYSE:ORCL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.